Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
Ann Rheum Dis. 2019 Apr;78(4):519-528. doi: 10.1136/annrheumdis-2018-214323. Epub 2019 Jan 23.
We examined genome-wide DNA methylation changes in CD8+ T cells from patients with lupus and controls and investigated the functional relevance of some of these changes in lupus.
Genome-wide DNA methylation of lupus and age, sex and ethnicity-matched control CD8+ T cells was measured using the Infinium MethylationEPIC arrays. Measurement of relevant cell subsets was performed via flow cytometry. Gene expression was quantified by qPCR. Inhibiting STAT1 and CIITA was performed using fludarabine and CIITA siRNA, respectively.
Lupus CD8+ T cells had 188 hypomethylated CpG sites compared with healthy matched controls. Among the most hypomethylated were sites associated with . Genes involved in the type-I interferon response, including , were also found to be hypomethylated. IFNα upregulated HLA-DRB1 expression on lupus but not control CD8+ T cells. Lupus and control CD8+ T cells significantly increased STAT1 mRNA levels after treatment with IFNα. The expression of CIITA, a key interferon/STAT1 dependent MHC-class II regulator, is induced by IFNα in lupus CD8+ T cells, but not healthy controls. CIITA knockdown and STAT1 inhibition experiments revealed that HLA-DRB1 expression in lupus CD8+ T cells is dependent on CIITA and STAT1 signalling. Coincubation of naïve CD4+ T cells with IFNα-treated CD8+ T cells led to CD4+ T cell activation, determined by increased expression of CD69 and cytokine production, in patients with lupus but not in healthy controls. This can be blocked by neutralising antibodies targeting HLA-DR.
Lupus CD8+ T cells are epigenetically primed to respond to type-I interferon. We describe an HLA-DRB1+ CD8+ T cell subset that can be induced by IFNα in patients with lupus. A possible pathogenic role for CD8+ T cells in lupus that is dependent on a high type-I interferon environment and epigenetic priming warrants further characterisation.
我们检测了狼疮患者和对照者 CD8+T 细胞中的全基因组 DNA 甲基化变化,并研究了这些变化在狼疮中的一些功能相关性。
使用 Infinium MethylationEPIC 芯片检测狼疮和年龄、性别及种族匹配对照者 CD8+T 细胞的全基因组 DNA 甲基化。通过流式细胞术测量相关细胞亚群。通过 qPCR 定量基因表达。分别用氟达拉滨和 CIITA siRNA 抑制 STAT1 和 CIITA。
狼疮 CD8+T 细胞与健康匹配对照者相比有 188 个低甲基化 CpG 位点。其中最显著的低甲基化位点与. 干扰素反应的基因,包括, 也被发现低甲基化。IFNα 在狼疮 CD8+T 细胞上调 HLA-DRB1 表达,但在健康对照者中没有。IFNα 处理后,狼疮和对照者 CD8+T 细胞的 STAT1 mRNA 水平显著增加。CIITA,一种关键的干扰素/STAT1 依赖性 MHC-II 调控因子,在狼疮 CD8+T 细胞中被 IFNα 诱导表达,但在健康对照者中没有。CIITA 敲低和 STAT1 抑制实验表明,狼疮 CD8+T 细胞中 HLA-DRB1 的表达依赖于 CIITA 和 STAT1 信号。与 IFNα 处理后的 CD8+T 细胞共孵育,导致狼疮患者而非健康对照者的 CD4+T 细胞活化,这可通过 CD69 表达增加和细胞因子产生来确定。该作用可被针对 HLA-DR 的中和抗体阻断。
狼疮 CD8+T 细胞在表观遗传学上已准备好对 I 型干扰素作出反应。我们描述了一种在狼疮患者中可由 IFNα 诱导的 HLA-DRB1+CD8+T 细胞亚群。CD8+T 细胞在狼疮中的致病性作用可能依赖于高水平的 I 型干扰素环境和表观遗传学的启动,这值得进一步研究。